Document pdjvLnpLZj7yp7gNK5bR6rkD

FILE NAME: Talc (TALC) DATE: 1976 Mar DOC#: TALC152 DOCUMENT DESCRIPTION: Meeting Minutes - CTFA Talc Task Force 1 The Cosmetic, Toiletry and Fragrance Association, Inc. 1133 151ft STREET, WASHINGTON, D.C, 2QQQ5 * 202/33-177Q * TELEX 89-2673 Jam es ti. Merritt Prtis NorWmeanf P. rm Estnn. dm jrf-- Ph 0. ft I ,K 0 T B S CTFA TALC TASK FORCE A m e e tin g o f -th e CTFA T lc Task F o r c e was h e ld on || a t t h e CTFA o f f i c e s in W ashington, D .C . Those in a tte n d a n c e w ere: G eorge S a n d la n d , B r is to l-M y e r s Company (Chairman) Jotm .E . C lem ents, "Pfizer, in e . Hay Krammer, W h itta k e r , C la r k -s D a n ie ls G e o r g e .L e e , Johnson .& Johnson Baby P ro d u cts Company Monroe- M es-sin ger, C hesebrouqh-P oiid*s I n c . .'R oderick A. -Mundv, S t e r lin g - Drug I n c .. ' L o u is D. M urino, Cyprus I n d u s t r ia l M in er a ls .Company 1D. R i ' B e t t e r son,, Johnson & Johnson Baby P rod u cts Company F red R o e sc h , W h itta k e r , C lark '& D a n ie ls " R ob ert R o l l e , Johnson & Johnson Baby P roducts company John P . S c h e l z , Johnson & Joh n son Baby P rod u cts Company M aurice S ie g e l, Faherge, in o . J ,C . .Si'ntko,' J r . , gESf Harold S ta n ly Ian Stewart," | Robert S u ffis , TheMennenCgnj S , 'Thompson,. ffipBmiKBny' John J . Travers* Avon P ro d u cts, In c . W illia m C. W aggoner, Johnson & Johnson .Baby P ro d u cts Cornoany Norman 1. s t r in , CTFA . Hr. Sandland opened the-m eeting and proceeded w ith th agenda. 1 . S ta tu s Review A. T a lc Standards, and Methods C op ies o th- proposed s p e c if ic a t io n and m ethods, p lu s co p ies o f a -le tte r to Dr. Schaffner w ere-distributed to ta s k fo r c e members. -B. A - s t a t u s , r e p o r t' (dated'M arch Sfch,. .1976) , prep^r.hl b y . D f. P e t te r son , on c o sm e tic t a l c s ta tu s was d is tr ib u te d t o t h o s e p r e s e n t . - X cop y o f art a r t ic le - by' .- CONTINUED ON NEXT PAGE D r- Rpftl and Dr., Arthur M. Langox on '`I d e n t i f i c a t i o n p u an -titation o f A sbestos in Talc" was d istr ib u ted a s i t a p p e a r s i n En v iro n m en ta l H e a lth P e r s p e c t iv e s , Volume 9 , 1974, pp. 95*109- .A lso* a copy o f th e c o r rectio n , to th e M arch-8 ,, 1976 Washington P ost a r t ic le oh t a lc and; t h e summary, o f th e '.d r a ft T a lk Paper a n t ic ip a t e d from t h e FDA w as d is t r ib u t e d t o t h o s e p r e s e n t . C. Win, Sam ples. ' Mr, S an d ian d summarized : t h e c o n t e n t s o f th e November, 197.5 l e t t e r from Henry DaVis (FDA) r e q u e s t in g OTFA. a p p ly i t s m eth od ology t o s e v e r a l' o f D r. Lewin sam p les p rovided on a coded-basis* The r e s u lt s o f the a n a ly ss were d escrib ed bv Dr. Rolle-. ' 2 Mfc., S i n a i A n a ly s e s on.O ld .P ro d u ctio n Sam ples Dr. F e t t e r so n g a v e d e t a i l e d background -an Dr* Danger ' s work. He' s t a t e d t h e o b j e c t i v e o f t h e t a s k f o r c e sh ou ld be t o de v elo p and c o lla t e d ata th a t would lead to presen tar ton before, th e-M iscellan eou s E xternal P a n el,-in . order to attem pt t o have t a l c p la ced in Category I . The r e s u lt s o f Dr. P o o le r 's a n a ly ses., sponsored by Johnson, s Johnson,, were summarized. * Ifc wM ^ P i M J M t _ D r . Langer p e r form ed h i s a n a v ls e s on samp i e _____________ h im s e lf and. D ^gft..Jae s4g-y*... He e s t i mated t h e samf-Xe MSlf-Mundy ( S t e r l i n g ) r e p o r te d on- h i s c o n t a c t s w ifii Dr. Langer and s t a t e d t h e sam ple Di?. Langer t e s t e d 3. R ecent P rod u ction Data i t was agreed by the task fo rce th a t .it'w ou ld be extrem a)y b e n e f i c i a l i f InduV idual com panies, c o u ld p r o v id e d a ta t n -the PDA.on r e c e n t p r o d u c tio n . Most com panies p r e se n t in d ic a te d t h a t'th e y p o ss s such data and would ha w illin g to provide t h e d a t a . Mr* M assinger (d h eseb rou gh -R on d 1s) s ta t s 'J. he would have to confirm t h is w illin g n e s s w ith h is management. I t w as-su ggested eachcompafty prepare a le tte r ,, addressed to D r. E -s tr in , w it h a summary o-f t h e d a ta on r e c e n t p r o d u c tio n fo r t h e ir p rod u cts and a commitment to s e t-u p a subsequent m e e tin g w it h FDA- t o d is c u s s t h i s d a t a , i n d e t a i l , i f FDA so d e s ir e s . T h is l e t t e r should be d e liv e r e d to Dr. E str in by Monday, March l'5th . S u b seq u en tly, a m eetin g was s e t-u p fo r t h a t Monday, March 1 5 th , at- t h e CTFA o f f i c e s , w ith a m eetin g a t FDA t o b e h e ld i n . t h e a fte r n o o n .' 4. CTFA S tu d y on C u rren t. P ro d u ctio n QE-CPC2-00000037 A d v a n ta g es and d is a d v a n t a g e s - o f h a v in g CTFA c o n t r a c t an in d e p e n d e n t la b o r a to r y t o do t e s t s on c u r r e n t p ir o lu c t io i sam p le s was d is c u s s e d , I t was n oted th a t, such d ata would no doub t b e u s e fu l,- n o t o n ly in d i s c u s s i o n s w ith FDA, b u t a ls o as. p a r t o f a p r e s e n t a t io n tD th e M is c e lla n e o u s E x te r n a l 'ne) nd, p erh a p s, to o th er p a n els as w ell* i t was su ggested the CTFA m eth o d o lo g y be u t i l i z e d f o r s u c h -a t a s k , b u t th a t TEM b e u se d on t h o s e sam p les t h a t h ave b een shown t o be p o s i t i v e oNt in pk d on next page SCSI # LEW1N- # PRODUCT ma 1339 1340 1341 1342 1343 1344 1345 1345 1347 1.348 1349 T350 1351 1352 72 77 95 9.7 101 1024 143 144B 151 154 IS 7.A 150 163 75 17 3A Lady Estpr Face Powder, Rachel Touch and Glow Face Powder Blanchard's Ousting Powder Born' Wild Dusting Powder, Del U b s Ta1 Winds Spray Talc, Avon Tosca Dusting Powder P1n-Zow Talqve, Perf. Beauty Prod. Overton's."High Brown" Face Powder Early American Old Spice Talcum Powder Bismol ine Medicated Powder Mavis. Imported Talcum Avon Beauty Oust Refill - Charisma Pinaud. Clubman Talc OHI de London Talc, Yardley Corsage Dusting Powder _ (om TREWOUTS LEHlN' " DOST X-RAY. uaur-" CHHYSOTHE ' Y-RAY DOST ND 2,300 f/mg. ND ND 3 5,500 ND ? 8 13,000 10 - 12 60,000 15 ND 15 8,900 ND ND o00 10 7 ND 5 400 10 - 5 ND ? ND ND 2,000 2 9,000 ND - ND - 5 NO 8 ND NO 9,000 trace ND 10 ? ID - ND - ND ? ND ND 7 ? by CTFA m eth od ology and a l s o be perform ed on a random b a s is on o th e r 'sam p les. . company r e p r e s e n ta tiv e s were p o lle d a t t h is m e e tin g and p r e v io u s l y by Mr, G eorge Lee t o d eterm in e w hether th e y would- be-, w i l l i n g to. p a r t i c i p a t e in such a stu d y by a s s u r in g th a t c u r r en t p rod u ction sam ples would be provided and th a t f i n a n c i a l su p p o rt.w o u ld be g iv e n . The r e s u l t s Would be made known t o t h e FDA and p fo b a b ly p u b lis h e d in some form . The fo llo w in g com panies in d ica ted th ey would be w illin g to p a r ti c ip a te ? A von.Products, Inc, .#BoriE t^otel-gMlayrlmfselc4ovmepiCan^yhany Faberge*. In c. , iohnson & Johnson Kennen S terlin g In a d d i t io n , Chesebrough-Pond *s , Mm,' and Y ard ly would prob ab ly be. in t e r e s t e d . The- t a s k f o r c e -agreed to a w a it t h e r e s u l t s o f th e m e e t in a s . w it h CTFA b e f o r e d e c id in g on w h eth er a stu d y on c u r r e n t produc tio n should be in itia te d . . The m e e tin g a d jo u rn ed i n order f o r a .s m a ll group t o m eet w ith FDA a t 2 :0 0 p.m . t o d i s c u s s t h e r e s u l t s o f CTFA a n a ly s e s o f Dr. L ew in 's sam ples. / * Jarman F . E s t r i n , P h.D , V ice P resid en t - Scien ce NFEi.jj March 1 2 th , 1976 QE-CPC2-I oo oo o